- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis ; volume:9 ; number:1 ; day:19 ; month:12 ; year:2012 ; pages:1-10 ; date:12.2012
Journal of neuroinflammation ; 9, Heft 1 (19.12.2012), 1-10, 12.2012
- Creator
-
Polak, Paul E.
- Contributor
-
Dull, Randall O.
Kalinin, Sergey
Sharp, Anthony J.
Ripper, Richard
Weinberg, Guy
Schwartz, David E.
Rubinstein, Israel
Feinstein, Douglas L.
SpringerLink (Online service)
- DOI
-
10.1186/1742-2094-9-272
- URN
-
urn:nbn:de:1111-2016032332745
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Polak, Paul E.
- Dull, Randall O.
- Kalinin, Sergey
- Sharp, Anthony J.
- Ripper, Richard
- Weinberg, Guy
- Schwartz, David E.
- Rubinstein, Israel
- Feinstein, Douglas L.
- SpringerLink (Online service)
Other Objects (12)
Neurodegeneration in multiple sclerosis mouse models
Dorsoventral photobiomodulation therapy safely reduces inflammation and sensorimotor deficits in a mouse model of multiple sclerosis
Cholesterol metabolism in mouse models of Multiple Sclerosis
Pharmacological postconditioning with sevoflurane after cardiopulmonary resuscitation reduces myocardial dysfunction
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis
Dendritic pathology in a mouse model of multiple sclerosis
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
Interferon-β1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis
Multiple sclerosis
Multiple sclerosis
Automated assessment of brain MRIs in multiple sclerosis patients significantly reduces reading time
Neurodegeneration in multiple sclerosis mouse models
Dorsoventral photobiomodulation therapy safely reduces inflammation and sensorimotor deficits in a mouse model of multiple sclerosis
Cholesterol metabolism in mouse models of Multiple Sclerosis
Pharmacological postconditioning with sevoflurane after cardiopulmonary resuscitation reduces myocardial dysfunction
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis
Dendritic pathology in a mouse model of multiple sclerosis
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
Interferon-β1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis
Multiple sclerosis
Multiple sclerosis
Automated assessment of brain MRIs in multiple sclerosis patients significantly reduces reading time
Neurodegeneration in multiple sclerosis mouse models
Dorsoventral photobiomodulation therapy safely reduces inflammation and sensorimotor deficits in a mouse model of multiple sclerosis
Cholesterol metabolism in mouse models of Multiple Sclerosis
Pharmacological postconditioning with sevoflurane after cardiopulmonary resuscitation reduces myocardial dysfunction
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis
Dendritic pathology in a mouse model of multiple sclerosis
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
Interferon-β1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis
Multiple sclerosis
Multiple sclerosis